SC 13G Filing

Company

Viking Therapeutics, Inc.

Filed

February 17, 2017

Accession Number

0001493152-17-001736

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →